Ardelyx (ARDX) Total Debt (2018 - 2026)
Ardelyx (ARDX) posted Total Debt of $203.5 million for Q1 2026, little changed on a QoQ basis from $202.8 million in Q4 2025, and up 34.51% year-over-year from $151.3 million in Q1 2025.
Ardelyx (ARDX) Total Debt (2018 - 2026) Analysis & Trends
Ardelyx's Total Debt history runs 9 years deep, the most recent figure standing at $203.5 million for Q1 2026.
- Quarterly Total Debt rose 34.51% year-over-year to $203.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $203.5 million (up 34.51% YoY) and the FY2025 annual result came in at $202.8 million, up 34.46% from the prior year.
- Total Debt was $203.5 million for Q1 2026 at Ardelyx, roughly flat from $202.8 million in the prior quarter.
- Across five years, Total Debt topped out at $203.5 million in Q1 2026 and bottomed at $26.7 million in Q4 2022.
- A 5-year average of $101.7 million and a median of $99.8 million in 2024 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2023 — Total Debt slumped 48.71% — and 2024, when it soared 271.41%.
- Ardelyx's Total Debt stood at $26.7 million in 2022, then soared by 86.52% to $49.8 million in 2023, then surged by 202.78% to $150.9 million in 2024, then surged by 34.46% to $202.8 million in 2025, then rose by 0.34% to $203.5 million in 2026.
- Business Quant data shows ARDX's Total Debt at $203.5 million in Q1 2026, $202.8 million in Q4 2025, and $202.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 959.06 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | 203.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 203.52 Mn |
| Dec 31, 2025 | 202.83 Mn |
| Sep 30, 2025 | 202.14 Mn |
| Jun 30, 2025 | 201.45 Mn |
| Mar 31, 2025 | 151.30 Mn |
| Dec 31, 2024 | 150.85 Mn |
| Sep 30, 2024 | 100.71 Mn |
| Jun 30, 2024 | 100.25 Mn |
| Mar 31, 2024 | 99.83 Mn |
| Dec 31, 2023 | 49.82 Mn |
| Sep 30, 2023 | 27.23 Mn |
| Jun 30, 2023 | 27.05 Mn |
| Mar 31, 2023 | 26.88 Mn |
| Dec 31, 2022 | 26.71 Mn |
| Sep 30, 2022 | 53.08 Mn |
| Jun 30, 2022 | 52.75 Mn |
| Mar 31, 2022 | 52.28 Mn |
| Dec 31, 2021 | 32.26 Mn |
| Sep 30, 2021 | 51.48 Mn |
| Jun 30, 2021 | 51.24 Mn |